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Vascular cognitive impairment (VCI) [vascular cognitive disorder (VCD), vascular dementia]
describes a continuum of cognitive disorders ranging from mild cognitive impairment
(MCI) to dementia, in which vascular brain injury involving regions important for memory,
cognition and behavior plays an important role. Clinical diagnostic criteria show moderate
sensitivity (ca 50%) and variable specificity (range 64–98%). In Western clinical series,
VaD is suggested in 8–10% of cognitively impaired elderly subjects. Its prevalence
in autopsy series varies from 0.03 to 58%, with means of 8 to 15% (in Japan
22–35%). Major types of sporadic VaD are multi-infarct encephalopathy, small vessel
and strategic infarct type dementias, subcortical arteriosclerotic leukoencephalopathy
(SAE) (Binswanger), multilacunar state, mixed cortico-subcortical type, granular cortical
atrophy (rare), postischemic encephalopathy, and a mixture of cerebrovascular lesions
(CVLs). They result from systemic, cardiac and local large or small vessel disease
(SVD); their pathogenesis is multifactorial. Hereditary forms of VaD caused by gene
mutations are rare. Cognitive decline is commonly associated with widespread small
ischemic vascular lesions involving subcortical brain areas (basal ganglia and hemispheral
white matter). The lesions affect neuronal networks involved in cognition, memory, and
behavior (thalamo-cortical, striato-subfrontal, cortico-subcortical, limbic systems). CVLs
often coexist with Alzheimer-type lesions and other pathologies; 25–80% of elderly
demented show mixed pathologies. The lesion pattern of “pure” VaD differs from that
in mixed dementia (AD + CVLs) suggesting different pathogenesis of both phenotypes.
Minor CVLs, except for severe amyloid angiopathy, appear not essential for cognitive
impairment in full-blown AD, while both mild AD-type pathology and SVD may interact
synergistically in promoting dementia. However, in a large percentage of non-demented
elderly individuals, both AD-related and vascular brain pathologies have been reported.
Despite recent suggestions for staging and grading CVLs in specific brain areas, due
to the high variability of CVLs associated with cognitive impairment, no validated
neuropathological criteria are currently available for VaD and mixed dementia. Further
clinico-pathological studies and harmonization of neuropathological procedures are needed
to validate the diagnostic criteria for VaD and mixed dementia in order to clarify the impact
of CVLs and other coexistent pathologies on cognitive impairment as a basis for further
successful therapeutic options.
Keywords: vascular dementia, vascular cognitive impairment, cerebral infarcts, large and small vessel disease,
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INTRODUCTION
Cerebrovascular disease (CVD) is increasingly recognized as a
cause of cognitive impairment and dementia in later life either
alone or in conjunction with Alzheimer disease (AD) or other
pathologies. Cognitive vascular disorder describes a heteroge-
nous group of disorders with different types of cerebrovascular
lesions (CVLs) contributing to cognitive decline and finally to
the development of dementia. Dementia related to vascular disor-
ders, first described as “arteriosclerotic dementia” (McMenemey,
1961), was later replaced by terms like “multi-infarct dementia”
[MID (Hachinski et al., 1974)], post-stroke dementia (Leys et al.,
2005), “vascular dementia” [VaD (Garcia and Brown, 1992)], and
recently by “vascular cognitive impairment” [VCI (Bowler, 2005;
Moorhouse and Rockwood, 2008; Rincon and Wright, 2013)].
“Vascular cognitive disorder” [VCD (Román et al., 2004)] is
a global diagnostic category encompassing all these disorders
that show a presumed vascular cause, while “subcortical vascu-
lar dementia” (SVaD) means a more homogeneous syndrome
(Erkinjuntti, 2002; Román et al., 2002; Bowler, 2005; Brown et al.,
2006; Tomimoto, 2011).
VCI/VaD increases the morbidity, disability, and healthcare
costs of the growing elderly population, and decreases their qual-
ity of life and survival (Knopman et al., 2003b; Fitzpatrick et al.,
2005; Hill et al., 2005; Sicras et al., 2005). Given the substantial
health and economic burden of VCI, its prevention and treatment
are critical research and clinical priorities.
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Consensus criteria for the clinical diagnosis of the major
dementing disorders have recently been updated, e.g., the revised
NIDS-ADRDA and EFNS criteria for AD (Dubois et al., 2010;
Sorbi et al., 2012), the National Institute on Aging-Alzheimer’s
Association (NIA-AA) criteria for AD (McKhann et al., 2011;
Reiman et al., 2011; Sperling et al., 2011; Sarazin et al., 2012),
for Parkinson disease dementia (PDD) (Dubois et al., 2007;
Emre et al., 2007), DLB (McKeith et al., 2005), frontotempo-
ral lobe degeneration (FTLD) (Josephs et al., 2011; Seltman and
Matthews, 2012), and other degenerative dementias (Karantzoulis
and Galvin, 2011; Lopez et al., 2011).
Previous diagnostic criteria for VaD required the presence of
memory loss and a severity of cognitive impairment sufficient to
adversely affect independent functioning consistent with demen-
tia (Chui et al., 1992; World Health Organization, 1992; Román
et al., 1993; American Psychiatric Association, 1994; Kuller et al.,
2005; Lopez et al., 2005). The National Institute of Neurological
disorders and Stroke-Canadian Stroke Network published har-
monization standards for VCI to address these potential limita-
tions and to provide a first step toward developing diagnostic
criteria for VCI (Hachinski et al., 2006). Other recent diagnos-
tic algorithms for VCI (Zhao et al., 2010), the NINDS-AIREN
DSM IV (Gorelick et al., 2011), the new EFNS-ENS guidelines
for the diagnosis and treatment of disorders associated with
dementia (Sorbi et al., 2012), and a proposal for new criteria
for VCDs (Sachdev et al., submitted) are suggested to be suitable
clinical approaches for assessing VCI patients, but await further
validation.
Despite multiple attempts, no generally accepted morphologic
substrates have been included in the currently used clinical diag-
nostic criteria for VaD (Román et al., 1993; Chui et al., 2000;
Hachinski et al., 2006). In contrast to recently refined morpho-
logic criteria for the diagnosis of AD and other degenerative
dementias, no morphologic scheme for quantifying CVD asso-
ciated with cognitive disturbances and no validated neuropatho-
logic criteria for VaD/VCI have been established so far (Jellinger,
2013).
Clinico-pathologic studies reported moderate sensitivity of
currently used clinical criteria (average 50–56%) and vari-
able specificity (range 64–98%, average 87%) with variable
interrater reliability (Gold et al., 2002; Chui, 2006; Bacchetta
et al., 2007; Jellinger, 2007a), while the Mayo clinical cri-
teria had 75% sensitivity and 81% specificity for autopsy-
proven VaD (Knopman et al., 2003a) (Table 1). However,
the demonstration of CVL by neuroimaging techniques or
autopsy does not prove that they definitely cause dementia
(Markesbery, 1998).
The present review, after discussing estimated prevalence and
epidemiology of VaD/VCD, focuses on its major morphologic
lesions, pathogenic factors, pathophysiology, and, finally, the
challenges of neuropathology involved in examining the role of
CVD in cognitive impairment.
PREVALENCE AND EPIDEMIOLOGY
Cognitive impairment occurs after stroke in 6–41% of patients
but can also arise from covert CVD (Ferrer, 2010; Pendlebury and
Rothwell, 2009; Allan et al., 2011).
Given the difficulties in diagnosing VaD, considerablemethod-
ological and geographical differences, there is considerable lack of
agreement about its epidemiology and prevalence.
In clinical studies, its prevalence ranges from 4.5 to 39%, in
Western memory clinic- and population-based series averages
8–15.8%, with standardized incidence rates (SIR) between 0.42
and 2.68, increasing with age (Table 2).
In clinical studies around Europe prevalence rates of VaD
between age 65–69 to 80+ years ranged from 2.2 to 16.3%, 20–40
to 200–700/100,000 and 0.7 to 6–8.1/1000 p/years (Fratiglioni
et al., 2000) or 39.0/1000 p/years at age 85–88 (Aevarsson and
Skoog, 1996); prevalence doubling every 5.3 years. In the US,
it increased from 0.2 to 16% (Bowler, 2005) or 3.9 to 19.1%
(Kuller et al., 2005), with double incidence at age 80+ in African
Americans compared to Caucasians (Fitzpatrick et al., 2005),
while in Japan the prevalence of VaD decreased after age 85+
(from 5.3 to 3.9%) (Kobayashi et al., 2009). In China, the preva-
lence for age 65+ was 4.8% for AD and 1.1% for VaD, with
age-related increase of AD from 0.5–1% to 35%, while the preva-
lence of VaD, after an increase up to 4% in the 9th decade,
decreased afterwards [see (Román, 2008)]. A meta-analysis per-
formed on 23 studies from Europe, USA, Taiwan, China, and
Japan found an increase in incidence and an exponential increase
over the age of 65 years for both AD and VaD (Jorm and Jolley,
1998).
A review of pathologic studies shows enormous differences
in the prevalence of VaD ranging from 0.03 to 85.2% with
means around 11%, while in recent autopsy series from Japanese
Table 1 | Diagnostic accuracy of possible VaD.
Clinical criteria Pathologic diagnosis Sensitivity Specificity
(%) (%)
VaD AD MD
(Bacchetta et al., 2007) 110 AUTOPSY CASES, MEAN AGE
94.6± 2.8 YEARS
(n = 36) (n = 26) (n = 48)
ADDTC possible 21 3 16 0.58 0.74
NINDS-AIREN poss. 20 3 17 0.56 0.73
HIS 20 3 22 0.56 0.66
(Knopman et al., 2003a) 89 AUTOPSY CASES
Mayo clinic 12 45 11 0.75 0.81
PREVIOUS AUTHORS (SEE Rocca and Knopman, 2003)
Average Average
0.49 (20–89) 0.88 (64–98)
Table 2 | Prevalence of VaD (clinical data) [from Jellinger (2008a)].
Increase with age (years) 65–69 90+
All dementias 0.8% 28.5%
AD (53.7 %) 0.6% 22.2%
VaD (15.8 %) 0.3% 5.2%
Increase with age 65–69 85+
Men 0.5% 3.6%
Women 0.1% 5.8%
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Table 3 | Autopsy series showing prevalence of VaD/VCI [modified
from Jellinger (2008b)].
1962–1990 15 studies (Europe, USA, Canada) 2784 cases
Prevalence 2.0–85.2% (mean 24.5%)
1962–1995 (Markesbery, 1998)
Prevalence mean 11.3%
1991–2003 (Riekse et al., 2004)
11 studies (USA, Scandinavia, Japan) 3438 cases
Prevalence 0.03–35% (mean 11.6%)
2004 Seattle, USA (Snowdon and Markesbery, 1999)
20/170 cases
Prevalence 7%
2009 Austria (Jellinger, 2009a): retrospective, dementia/AD
1700/950 cases
Prevalence 13.3/3.1% Jellinger (unpublished):
prospect.
Dementias
300 cases
Prevalence 9.0%
2009 Honolulu—Japan (White, 2009)
Demented, 183 cases
Prevalence 33.8 %
2010 Brazil (Nitrini et al., submitted)
Demented, 206 cases
Prevalence 31.8%
Japan (Seno et al., 1999; Akatsu et al., 2002)
122/270 cases
Prevalence 35.0/23.6%
geriatric hospitals it was 23.6 to 35% (Table 3). In autopsy series
of elderly subjects with and without dementia, the prevalence of
“pure” VaD (without concomitant cerebral pathologies) ranged
from 5 to 78%, in the oldest-old from 4.5 to 46.8% (Jellinger
and Attems, 2010b). The majority of patients showed Alzheimer-
related pathology, only part of them with AD alone, while mixed
pathologies, i.e., AD plus cerebrovascular or Lewy pathology, were
seen in 74–93% and 9–28%, respectively (Table 4). In the age
group 70 to 90+, the prevalence of VaD increased from 13 to
44.8%, compared to AD (23.6–57%) and mixed dementia (2–
86%) (Table 5). In a consecutive autopsy series of 1700 elderly
demented, AD without concomitant pathologies or minor CVLs,
and mixed dementia increased with age. Whereas the prevalence
of “pure” VaD decreased after age 80+ (Figure 1).
The prevalence studies must be interpreted cautiously due
to referral biases, confounding effect of their comparison by
the lack of common diagnostic criteria for VaD, small num-
bers of very old individuals in most studies (Xuereb et al., 2000;
Polvikoski et al., 2001; Kawas and Corrada, 2006; Zaccai et al.,
2006), and the fact that aged subjects with and without dementia
show a high frequency of mixed pathologies and comorbidities
(Jellinger, 2007a,b; Schneider et al., 2007a,b; James and Schneider,
2010).
VESSEL DISORDERS CAUSING CEREBROVASCULAR
LESIONS
The vessel disorders that are most frequently associated with
VaD are atherosclerosis of cerebral arteries (AS), arteriosclero-
sis or cerebral small vessel disease (SVD), and cerebral amyloid
angiopathy (CAA) (Ince, 2005; Hachinski et al., 2006; Kalaria and
Erkinjuntti, 2006; Hauw et al., 2008; Ferrer, 2010; Attems et al.,
2011). These vessel disorders frequently occur in the brains of
elderly individuals and become more prevalent and severe with
advancing age (Jellinger and Attems, 2010a). There are less com-
mon forms of CVD, including various types of vasculitis and
inherited diseases that affect vessel integrity, some of which are
associated with the development of dementia in the absence of
AD, e.g., CADASIL.
Atherosclerosis (AS) is a degenerative disorder of large and
medium sized arteries that leads to intima proliferation and
accumulation of cholesterol within the vessel wall. These pro-
cesses result in the generation and calcification of atherosclerotic
plaques, that rupture frequently and induce local thrombosis. It
can cause large brain infarcts, whereas embolism of atherogenic
thrombi can lead to a broad variety of infarcts (Liberato et al.,
2005; Grinberg and Thal, 2010).
Small vessel disease (SVD) comprises small vessel arterioscle-
rosis, lipohyalinosis, and arteriolosclerosis. These vessel wall
changes are similar to that of larger blood vessels except for cal-
cifications not seen in small arteries (Lammie, 2005; Hachinski
et al., 2006). SVD can result in lacunar infarcts, microinfarcts,
hemorrhages, and microbleeds (Vinters et al., 2000; Grinberg
and Thal, 2010). It affects first arteries of the basal ganglia, then
expands into the peripheral white matter, leptomeningeal arter-
ies, and into thalamic and cerebellar white matter vessels, and,
finally, involves brain stem arteries. Cortical vessels are usually not
involved in SVD (Thal et al., 2003).
Cerebral amyloid angiopathy (CAA). Sporadic CAA is char-
acterized by the deposition of the amyloid β-protein (Aβ) in
the wall of leptomeningeal and cerebral blood vessels (Attems
et al., 2011). These deposits are located near the basement mem-
brane or in the smooth muscle cell layer. CAA can lead to vessel
wall rupture and hemorrhage, microbleeds, capillary occlusion,
blood flow disturbances, and to microinfarcts (Thal et al., 2009;
Okamoto et al., 2012). In familial forms severe CAA can be
caused by Aβ as well as by the deposition of other proteins, e.g.,
prion protein and cystatin C, etc. (Revesz et al., 2009). CAA
most frequently involves leptomeningeal and neocortical arter-
ies, veins, and/or capillaries, later vessels in allocortical regions
(hippocampus, entorhinal and cingulate cortex, amygdala). The
hypothalamus and the cerebellum exhibit CAA as well, whereas
blood vessels of the brainstem are involved later (Thal et al.,
2003).
Intracranial hemorrhages (ICHs), including large lobar hem-
orrhages, deep bleeds in the basal ganglia, microscopic brain
hemorrhages or cerebral micro-bleeds (CMBs), microinfarcts
(seen only in microscopic sections), and subarachnoid hemor-
rhages may all be caused by SVD. It may also cause white matter
hyperintensities (WMHs), lacunes and both ischemic and hem-
orrhagic infarcts. The prevalence and incidence of SVD increases
with age, however, the prevalence of the lesions caused by SVD
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Table 4 | Frequency of mixed pathologies in autopsy series of elderly subjects.
Pathologies (%)*
Author N AD lesions AD alone AD + CVL AD + LBD VaD DLB FTD Others
Galasko et al., 1994 170 (d) 56.5 7.1 – 2.4 22.4 11.8
Victoroff et al., 1995 196 (d) 44.9 12.8 – 4.6 6.6 31.3
Jellinger, 1996 540 (d) 65.0 4.1 – 8.5 6.1 2.8 13.5
Nolan et al., 1998 87 (d) 100 50 34 – –
Lim et al., 1999 ? ? 36 45 22 –
NUN studyRiley et al., 2002 57 73/93 – –
Akatsu et al., 2002 158 (d) 46.2 5.7 21.5 17.7 3.2 5.7
382 (d) 41.6 11.3 3.1 22.0 4.7 17.3
202 (d) 63.9 9.5 5.9 11.9 4.6 11.9
HAAS studyPetrovitch et al., 2005 333 (235 d, 98 contr.) <60 20 45 – 24
MRC-CFAS (UK)Fernando and Ince, 2004 209 (48% d) 70 21 – – 78
Andin et al., 2005 175 (clin. VaD) – 72 – 28
Jellinger, 2009b (retrospective) 1700 (d) 79.5 44.8 25.3 9.0 13.3
Jellinger, 2009b (prospective) 180 (d) 82.7 48.8 23.9 10.0 7.8
Nitrini et al., submitted 110 (d) 43.6 28.1 15.5 (9.9) 31.8
Brunnstrom et al., 2009 524 (d) 42.0 21.6 23.7 0.2 4.0 8.6
Schneider et al., 2007a 141 (35% d) 82.7 30 38 12 12
AD, Alzheimer disease; CVL, cerebrovascular lesion; LBD, Lewy body disease; VaD, “pure” vascular dementia; d, demented.
*AD + other pathologies and other dementing disorders are not included.
Table 5 | Types of dementia in oldest-old subjects—autopsies.
% of total autopsy cases of each cohort
Author n Mean age (years) AD VD MIX DLB Others
Mizutani and Shimada, 1992 27 (100–106) 33.3 18.5 22.0 15.0 12.0
Seno et al., 1999 122 83.6 ± 8.2 34 35 11 − 20
Akatsu et al., 2002 158 72–91 46 22 2 18 12
Riekse et al., 2004 270 80.7 ± 5.6 12 (70%F) 7 (30%F) ? ? ?
White et al., 2005 363 85.5 19 27.5 39.5a 14b
Jicha et al., 2006 34 89.0 64.7 11.7 6.0 17.6 0
Bacchetta et al., 2007 110 90+ 23.6 32.7 46.4 − −
Schneider et al., 2007a 141 86 26 16 86c 17 ?
Grinberg et al., 2009 206 75.6 33.6 46.8 22.4 − −
Jellinger, 2008b 1680 83.3 ± 5.6 46.4/21.0c 13.1 4.8 8.5 6.3
Jellinger, 2009b 300 90+ 41/32 9 12 4 2
Schneider et al., 2009a
Community cohort 194 89.8 ± 5.5 49.45 39.2 44.3 24.7 1.5
Clinical cohort 280 79.2 ± 10 66.1 17.9 27.5 21.4 6.1
Schneider et al., 2009b 179 89.7 ± 56 57.5 4.5 30.2 1.1 6.2
Brayne et al., 2009 113 91 (81–101) 67 35 26 5 ?
White, 2009 183 72–90+ 18.6 33.8 14.2 10.9 22.5
Jellinger and Attems, 2010a 1700 84.3 ± 5.6 45.7/25.0c 12.8 5.7 10.7d 4.2
Echavarri et al., 2012 200 78.7 26 2.0 28 0.5 47.5
Corrada et al., 2012 63 94 (90–104) 57 13.0 13.0 17.0
a20.5% AD + CVLs, 10% Lewy neurites, 9% hippocampal sclerosis;
bno cause of dementia identified; cAD + CVLs;
d AD + LBs, AD, Alzheimer’s disease.
VD, vascular dementia; MIX, mixed dementia (AD + cerebrovascular encephalopathy), CVD, cerebrovascular dementia; DLB, dementia with Lewy bodies; CVLs
cerebrovascular lesions; LBs, Lewy bodies.
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FIGURE 1 | Age-related frequency of neuropathologic types of dementing disorders. AD, Alzheimer’s disease; CVD, cerebrovascular dementia; LBD, Lewy
body dementia; VaD, vascular dementia; MIX, mixed dementia (AD + cerebrovascular encephalopathy).
varies in the oldest old: macroscopic ICHs are comparatively rare,
while microscopic hemorrhages and CMBs that are often asso-
ciated with severe CAA (Tanskanen et al., 2012) are frequent. In
non-demented elderly subjects, lacunes, CMBs and WMHs have
been associated with cognitive decline, including reduced mental
speed and impaired executive functions (Seo et al., 2007) or other
neuropsychiatric symptoms. SVD is more common in subjects
with AD, and might interact with the neurodegenerative changes
in AD as either independent of each other (Esiri et al., 2012) or
due to additive or synergistic effects on cognitive decline (Zekry
et al., 2003c).
MORPHOLOGICAL SUBSTRATES OF VASCULAR COGNITIVE
DISORDER
VCI/VaD is the net result of vascular lesions that lead to impair-
ment of brain function (Jellinger, 2007a, 2008a; Ferrer, 2010;
Levine and Langa, 2011). Pathologic changes in patients with
VCI representing a variety of large and small cerebrovascular and
ischemic lesions involving various cerebral lesions are multifold
(Table 6). They include focal, multifocal, and diffuse lesions (Thal
et al., 2012).
The patterns of the vascular brain lesions leading to dementia
distinguish three major forms of VaD: 1. multi infarct demen-
tia, 2. strategic infarct dementia, and 3. subcortical vascular
encephalopathy (Figure 2).
1. Multifocal lesions include large territorial infarcts due to large
vessel disease, distal field (watershed/borderzone) infarcts,
mainly related to hemodynamic events and carotid artery
Table 6 | Major cerebrovascular lesions associated with cognitive
impairment.
1. Gross large infarcts in supply territories of large cerebral arteries, in
particular ACM, ACM+ACP, unilateral or bilateral
2. Lacunes (lesions 0.5–15mm (Ø) and multiple microinfarcts or small
hemorrhages in basal ganglia, thalamus, hippocampus, basal forebrain
(“strategic infarct dementia”)
3. Multiple microinfarcts/scars in cortical border zones (“granular cortical
atrophy”)—rare
4. Pseudolaminar cortical necrosis (mainly arterial border zones)
5. Hippocampal sclerosis
6. White matter lesions/leukoaraiosis/Binswanger disease
7. Combined cerebrovascular lesions
ACM, middle cerebral artery; ACP, posterior cerebral artery.
stenosis, microinfarcts throughout the brain, often due to
embolic disease, small and medium-sized lesions in subcor-
tical functionally important brain areas, lacunes, and white
matter lesions (WML). Others are subcortical arteriosclerotic
leukoencephalopathy (SAE) or Binswanger’s disease, result-
ing from chronic hypoperfusion (Ince, 2005; Farkas et al.,
2006), cortical pseudolaminar necrosis due to global ischemia
and hypoperfusion, hippocampal sclerosis and multiple post-
ischemic lesions (Jellinger, 2007a).
2. Focal disease includes circumscribed unilateral or symmet-
ric lesions, often involving functionally important brain
areas and neuronal circuits (thalamus, medial temporal
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FIGURE 2 | Schematic representation of multi infarct dementia, strategic
infarct dementia, and subcortical vascular encephalopathy. The gray
areas mark the regions where infarcts and white matter lesions are located.
In multi infarct dementia multiple microinfarcts, lacunar infarcts, and small
large infarcts are distributed all over the gray matter. Strategic infarct
dementia is characterized by infarcts in strategic regions that alone explain
dementia, i.e., in the hippocampal formation and in the paramedian nuclei of
the thalamus. Subcortical vascular encephalopathy is characterized by
confluent white matter lesions in the central and peripheral white matter.
Small infarcts in subcortical brain regions may also co-occur with this type of
VaD. Amy, amygdala; CA1, Ammon’s horn sector CA1; Cing., cingulate gyrus;
CN, caudate nucleus; ER, entorhinal cortex, F, frontal neocortex; Hypoth,
hypothalamus; NBM, basal nucleus of Meynert; ST, striatum, T; temporal
neocortex; Thal, thalamus. After Thal et al. (2012).
lobe/hippocampus, frontal and basal forebrain, etc.). They are
caused by vascular and ischemic mechanisms due to large
and SVD, cardiac embolic events, hemodynamic events and
cerebral ischemia of various etiology, e.g., degenerative or
inflammatory angiopathies, genetic arteriopathies, and other
rare causes (Esiri et al., 1997; Kalaria et al., 2004; Román
et al., 2004; Jellinger, 2005, 2007a; Kalimo and Kalaria, 2005;
Hauw et al., 2008; Ferrer, 2010). Cardiac sources, such as atrial
fibrillation and myocardial infarction, provide a source for
cerebral emboli, whereas most other causes, such as hemato-
logical conditions, inflammatory angiopathies, Sneddon’s dis-
ease and familial CVD, e.g., autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy (CADASIL)
(Chabriat et al., 2009) or CAA, both sporadic [see (Attems
et al., 2011)] and hereditary (Kalimo and Kalaria, 2005; Revesz
et al., 2009), usually cause multiple subcortical and/or cortical
vascular lesions (Thal et al., 2012).
Another classification distinguishes lesions related to large and
SVD (Table 7).
1. Large vessel dementia: Classical multi-infarct encephalopathy
(MIE) is characterized by multiple large and small infarcts
involving the areas of major cerebral arteries—(sub)territorial
lesions of variable size, due to atherosclerosis of extra- and
intracranial vessels giving rise to local thromboembolism or
hypoperfusion, and cardiac sources of cerebral emboli, while
inflammatory angiopathies and hereditary arteriopthies, e.g.,
CADASIL, more frequently cause lacunar infarcts (Ince, 2005;
Hauw et al., 2008; Ferrer, 2010). Occlusion or stenosis of
extracranial arteries, e.g., the internal carotid artery (ICA) and
the major intracranial arteries can lead to MIE. It accounts for
about 15% of VaD, the dominant hemisphere being more fre-
quently involved. Medium-sized arteries in the leptomeninges
and proximal perforating arteries can be involved.MID cannot
be linked to a specific vessel disorder. Its relation to age-related
vessel disorders varies and a combination of vascular lesions
is frequently seen. Atherosclerosis of cerebral arteries shows
a trend to more severe lesions in the circle of Willis in VaD
cases than in cognitively normal controls suggesting that AS-
related thrombosis and embolic events are important for this
type of VaD. This trend is supported by the finding that the
likelihood of dementia is increased in the presence of high-
grade ICA atherosclerosis (Suemoto et al., 2011). The damage
can be worse depending upon the presence of hypertension
and related CVD.
2. Small vessel disease (SVD)/microangiopathic dementia: This
type is characterized by the presence of lacunes or microin-
farcts and microbleeds, predominantly involving central white
matter and subcortical structures including thalamus, basal
ganglia, internal capsule, brainstem, and cerebellar white
matter. They are caused by hypoperfusion due to age- and
hypertension-related changes of microvessels (microvascu-
lar fibrosis, stenosis and occlusion), and damage of the
blood-brain barrier (BBB), etc. (Rosenberg, 2012). Lacunar
infarcts are small miliary softenings from 3 to 15mm in
diameter or small cavitations that may have more than one
pathologic substrate, the most significant representing small
infarcts and, less frequently, healed, or reabsorbed tiny hem-
orrhages (Lammie, 2005; Jellinger, 2007a) that are detected by
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Table 7 | Classification of VaD according to major morphologic
lesions (modified from Jellinger, 2007a).
A. MULTIFOCAL/DIFFUSE DISEASE
1. Large vessel dementia (LVD)
Multiple infarct dementia (MID): Multiple large artery/borderline
infarcts, cortical and subcortical, with perifocal lesions in gray and
white matter.
2. Small vessel dementia (SVD)
Subcortical infarct dementia:
Multiple small lacunar infarcts with perifocal lesions in white
matter.
“Granular atrophy” of cortex (multifocal cortical microinfarcts)
Lacunes and multilacunar state
Binswanger subcortical (leuko)encephalopathy
Hereditary angiopathies—CADASIL (cerebral autosomal
dominant arteriopathy with subcortical infarcts and
leukoencephalopathy) and others
Cortical plus subcortical infarct dementia:
Multiple, restricted small infarcts due to:
Hypertensive and arteriolosclerotic angiopathy
Cerebral amyloid angiopathy, with/without hemorrhages
Collagen or inflammatory vascular disease (angiitis, PCNSA,
FMD)
Hereditary forms of CAA
3. Hypoperfusive, hypoxic-ischemic dementia (HHD)
Incomplete white matter infarcts
Anti-PL related ischemia
Diffuse hypoxic-ischemic encephalopathy (cortical lacunar necrosis,
post cardiac arrest, hypotension)
4. Venous infarct dementia
Large hemorrhagic, congestive symmetric infarcts due to
thrombosis of the sagittal sinus or the great vein of Galen
5. Hemorrhagic dementia
Subdural hemorrhage
Subarachnoid hemorrhage
Intracerebral hemorrhage
Multiple microbleeds, particularly subcortical
B. FOCAL DISEASE/STRATEGIC INFARCT DEMENTIA (SID)
Small infarcts restricted to functional important regions
Mesial temporal (including hippocampal) infarcts/ischemia/
sclerosis
Caudate and thalamic infarcts (especially DM nucleus,
bilateral lesions)
Fronto-cingulate infarcts (basal forebrain, ACA)
Angular gyrus infarct (dominant cerebral hemisphere - ACA
and MCA territories)
White matter key areas
Anti-PL, anti-phospholipid; PCNSA, primary angiitis/arteritis of the central ner-
vous system; FMD, fibromuscular dysplasia; ACA, anterior cerebral artery; DM,
dorsomedial; CAA, cerebral amyloid angiopathy.
modern neuroimaging methods and upon histological exam-
ination (Figures 3, 4). Lacunes were found in 32–42% of
patients studied, representing the most frequent type of CVLs
(Jellinger, 2007a). Cerebral microinfarcts, minute foci with
FIGURE 3 | Confluent deep white matter hyperintensities in female
aged 78 years with mild cognitive impairment. (A) T2-weighted
FLAIR-MRI scan. (B) Multiple small areas of patchy myelin loss and lacunes
in both cerebral hemispheres (Kluver-Barrera stain).
FIGURE 4 | Confluent hyperintensities in deep and periventricular
white matter in 77 years old female without neuropsychiatric disorder
or cognitive impairment. (A) T2-weighted FLAIR-MRI scan. (B) Multiple
white matter changes with patchy myelin loss, perivascular empty spaces,
small lacunes, and periventrivular myelin pallor (Kluver-Barrera stain).
neuronal loss, gliosis, pallor, or more cystic lesions, found in
all brain regions, possibly more in cerebral cortex, particularly
in watershed areas, are frequent in patients with VaD (average
62%), compared with nondemented older individuals. They
are an important correlate of CVL (Brundel et al., 2012; Smith
et al., 2012).
Cerebral microbleeds (CMBs) are histologically defined as
blood extravasations into the perivascular and/or Virchow-
Robin space usually without disruption of the surrounding
tissue and/or very small intracerebral hemorrhages measuring
less than 5mm in diameter. Hemosiderin-laden macrophages
and hemosiderin depositions within the perivascular space are
generally considered to indicate prior CBMs (Grinberg and
Thal, 2010). The walls of ruptured arterioles may show CAA
related vascular damage, with thickened acellular morphol-
ogy, lack of the muscular layer and Aβ deposition. In addition,
ruptured microvessels affected by hypertensive angiopathy
or atherosclerosis may be associated with CBMs (Vernooij
et al., 2008; Poels et al., 2010; Hommet et al., 2011). CMBs
potentially could also correspond to focal accumulations
of hemosiderin containing macrophages in the perivascu-
lar space that are unrelated to previous bleedings. There is
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evidence of heme degradation activity within a surround-
ing inflammatory reaction with activated microglial cells, late
complement activations and apoptosis (Schrag et al., 2010).
The relevance of CMBs for cognitive impairment remains
uncertain (Charidimou and Werring, 2012; Van der Flier and
Cordonnier, 2012).
Small vessel lesions can be distinguished according to the
type and predominant location (Table 7):
(a) (Multi)lacunar state with multiple cortico-subcortical
microinfarcts or lacunes
(b) “Strategic” infarct dementia (SID) with solitary or mul-
tiple small infarcts in functionally important brain areas
(thalamus, frontocingular cortex, basal forebrain, mesial
temporal area, and hippocampus) that cause cognitive
deficits when damaged by CVLs) (Kalaria and Erkinjuntti,
2006; Jellinger, 2007a, 2008a; Ferrer, 2010). They can be
caused by SVD and embolic events. CAA (except for famil-
ial CAA cases) is usually not associated with thalamic or
hippocampal infarcts, although capillary CAA-associated
vessel occlusion have been reported in the CA1-subiculum
and thalamus (Thal et al., 2008, 2009).
(c) Watershed or borderzone (cortico-subcortical) infarcts
in cerebral convexities or end-field territories between
small deep and superficial vessels (hippocampal, tha-
lamic infarcts) caused by diminished perfusion due to
atherosclerosis, prolonged episodes of hypotension.
(d) Subcortical arteriosclerotic (leuko) encephalopathy type
Binswanger (SAE) associated with confluent WMLs or
“leukoaraoisis.” The pathology of WMLs includes a triad
of demyelination, axonal loss and lacunar infarcts in the
periventricular/deep and subcortical white matter rang-
ing from dilatation of the Virchow–Robin spaces to diffuse
myelin pallor and microinfarcts, usually sparing the sub-
cortical U-fibers related to the specific pattern of vascular
supply. They are caused by microvascular changes due to
arteriosclerosis, hyalinosis and focal fibrinoid necrosis of
vessels with and without occlusion. SVD may be associ-
ated with dilatative arteriopathy (Pico et al., 2007). These
changes may not only occur in the lesions, but also in nor-
mal appearing white matter as well (Brown et al., 2007).
Morphologic, experimental and molecular studies suggest
that WMLs result from chronic ischemia due to hypoper-
fusion and disturbances of cerebral blood flow (CBF), and,
alternatively recurrent edema resulting from disturbances
of the BBB (Pantoni, 2002; Fernando et al., 2006). The
morphologic features, pathogenesis and clinical relevance
of WMLs have been reviewed (see Englund, 2004; Inzitari
et al., 2007; Jellinger, 2007a; Simpson et al., 2007; Schmidt
et al., 2011), but still need further validation. CADASIL
can cause a similar pattern of subcortical lesions (Kalimo
and Kalaria, 2005).
3. Other types of VaD include
(a) Post-ischemic encephalopathy that can be separated into
three major groups according to their predominant dis-
tribution pattern:
• Cortical laminar necrosis and their sequelae resulting
from cardiac or respiratory arrest, often occurring in
arterial border zones and associated with diffuse white
matter damage.
• Multiple post-ischemic lesions after hypotension and
focal narrowing of brain-feeding vessels, leading to
multiple cortical and subcortical (micro)infarcts.
• Hippocampal sclerosis (HS), a relatively common neu-
ropathological finding (∼10%) in individuals over age
85, is characterized by cell loss and gliosis that is not
explained by AD. Caused by hypoxic-ischemic etiol-
ogy in old subjects with cardiac failure and cerebral
hypoperfusion it is often associated with dementia
(Corey-Bloom et al., 1997; Attems and Jellinger, 2006;
Hachinski et al., 2006; Ferrer, 2010) and has been repro-
duced in animal models of VaD (Hartman et al., 2005;
Ishibashi et al., 2006). However, HS is also associated
with a variety of neurodegenerative disorders, such as
frontotemporal lobar degeneration (FTLD) and tau-
pathies (Beach et al., 2003; Amador-Ortiz et al., 2007).
A specific subtype is associated with progressed age
(Nelson et al., 2011). Age at death and clinical features
of HS associated with age were distinct from previously
published cases of FTLD. In a recent autopsy study
TDP-43 pathology was seen in 18% of cases with HS, in
35% of those with cognitive impairment and in 46% of
cases with severe concomitant AS pathology (Rauramaa
et al., 2011). Hence, HS may incorporate different sub-
types: HS—CVD (Kril et al., 2002), HS—tau (Beach
et al., 2003; Miki et al., 2009), HS—FTLD (Hatanpaa
et al., 2004), and HS associated with advanced age
(Nelson et al., 2011).
(b) Hemorrhagic dementia. Primary intracerebral hemor-
rhages, varying in size and location, are uncommon causes
of dementia, except for multiple cortical and subcor-
tical microbleeds, usually associated with hypertension
(Markesbery, 1998; Cordonnier et al., 2007; Seo et al.,
2007).
(c) The role of CAA in cognitive impairment. The majority
of dementing disorders related to cerebral hemorrhages
or hemorrhagic infarcts occur in sporadic and heredi-
tary conditions associated with CAA (Zhang-Nunes et al.,
2006; Revesz et al., 2009), and other hereditary forms
of VaD (Kalimo and Kalaria, 2005). Sporadic CAA, for
which an assessment protocol has recently been suggested
(Table 8), may cause WMLs and may represent an inde-
pendent risk factor for cognitive decline (Pfeifer et al.,
2002; Zekry et al., 2003b; Greenberg et al., 2004; Jellinger
andAttems, 2005; Chen et al., 2006). This is, however, only
valid for a subgroup of demented patients lacking consid-
erable neuritic AD pathology, whereas in the majority of
cases the topographical distribution of CAA and its effect
on cognitive decline are influenced by AD-pathology
(Attems et al., 2007). Severe CAA is often related to corti-
cal microinfarcts (Haglund et al., 2006), but hypertension
has also an important role, and both human and experi-
mental studies suggest that cerebrovascular effects of Aβ
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Table 8 | Suggested protocol for the assessment of cerebral amyloid angiopathy and concomitant vasculopathy (Chalmers et al., 2013).
Score Parenchymal CAA Meningeal CAA Capillary Vasculopathic Examined Vasculopathy
CAA score region description
0 Absent Absent Absent Absent Frontal FN, hemorrhage
1 Scant deposition Scant deposition Present Occasional vessel Temporal FN
2 Some circumferential amyloid Some circumferential amyloid Many vessels Parietal FN
3 Widespread circumferential amyloid Widespread circumferential amyloid Occipital FN
median
peptide render the brain more vulnerable to ischemic
injury (Zekry et al., 2002; Iadecola, 2003). Recently CAA
has been shown to be a less frequent cause of sponta-
neous (non-traumatic) brain hemorrhages in the aged
than considered previously (Jellinger et al., 2007).
PATHOGENIC FACTORS
Vascular risk factors (hypertension, hyperlipidemia, diabetes) and
behavioral factors (obesity, physical inactivity) are associated with
both CVD and, when present in mid-life, dementia (O’Donnell
et al., 2010). Studies in middle-aged or older adults have found
associations between VCI and hypertension (Kuller et al., 2005),
hyperlipidemia (Solomon et al., 2009), diabetes (Ahtiluoto et al.,
2010), obesity, and physical inactivity (Staekenborg et al., 2008).
Several pathogenic mechanisms including AD, amyloid deposi-
tion, aging, atherosclerosis, and hypertension may converge to
cause CVD and dementia through pathways of inflammation and
oxidative stress in blood vessels (Iadecola et al., 2009). Vascular
risk factors may lead to cerebrovascular dysfunction through
pathways mediated by β-amyloid and the enzyme nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase, a major
source of vascular oxidative stress. Cerebrovascular dysfunction
and BBB alterations may compromise the cerebral microenviron-
ment and increase the vulnerability of regions critical for cogni-
tion to ischemic-hypoxic brain damage leading to neuronal dys-
function and cognitive deficits (Iadecola et al., 2009). Atrial fib-
rillation may cause microembolic complications that lead to VCI
(Puccio et al., 2009) or accelerate cognitive and functional decline
(Purandare et al., 2007). Recent datamay implicate clot formation
and microinfarctions as mechanisms of VCI through hemostatic
pathways (van Oijen et al., 2005). Other studies suggest potential
roles of inflammation in VCI (Yamamoto et al., 2005).
Genetic factors may influence the development or course of
VCI. ApoE ε4 and ε2 with their potential amyloidogenic role may
be responsible for some of the microvascular changes in VaD
(Yip et al., 2005; Baum et al., 2006). CADASIL, a genetic form of
SVaD, is associated with Notch3 mutations whose location may
differ by geography or demography (Chabriat et al., 2009). The
identification of phenotypes that can be reliably and effectively
determined in large samples of subjects is a critical challenge for
genetic studies of VCI (Leblanc et al., 2006; Jones et al., 2011).
Important pathogenic factors of VaD/VCD include the vol-
ume of brain destruction, its location and the number of CVLs,
although the overlap between vascular and degenerative mech-
anisms and a frequent lack of correlation between clinical and
pathology findings ware emphasized (Pantoni, 2003). The vicious
circle of pathogenic factors related to VaD/VCD is summarized in
Figure 5.
VOLUME OF BRAIN DESTRUCTION
Patients with brain tissue losses of more than 100ml suffered
from dementia and infarcts between 50 and 100ml produced
dementia less consistently, but dementia also occurred with
infarcts of smaller volumes. Demented patients showed signifi-
cantly more frequent infarcts >20ml than controls, and a dif-
ference between both groups was present at 50ml tissue loss
cut-off (Tomlinson et al., 1970). According to this study, which
has never been replicated, relatively small infarcts may or may
not contribute to dementia, probably depending on their loca-
tion, whereas destruction of large parts of the cortex are usually
followed by dementia. Therefore, the concept of strategic sites of
infarcts was proposed. Macroscopic studies in VaD revealed mean
volumes of infarcted brain loss of 39–47ml (range 1–229ml)
(Zekry et al., 2003a), while others suggested that dementia is not
consistently related to the volume of infarction (del Ser et al.,
1990) or found only a nonsignificant trend for lobar infarcts to
occupy more brain volume than in patients without dementia
(Vinters et al., 2000).
LOCATION OF VASCULAR LESIONS
Location of CVLs is more important than the volume of tissue
destruction. Multiple brain areas have been implicated in VaD:
infarction in the dominant hemisphere or bilateral lesions with
predominant involvement of the dominant hemisphere as well as
those in left angular gyrus, left or bilateral ACA and PCA terri-
tories increase the risk of dementia after stroke (del Ser et al.,
1990). Bilateral thalamic infarction and lacunar lesions in basal
ganglia, head of the caudate nucleus and inferior genu of the
anterior capsule, interrupting corticothalamic and thalamocorti-
cal pathways, have been associated with “subcortical dementia”
(Erkinjuntti, 2002; Van derWerf et al., 2003; Chabriat et al., 2009).
Hippocampal infarcts and sclerosis either alone or in combina-
tion with other vascular lesions have been related to dementia
(Attems and Jellinger, 2006; Hachinski et al., 2006). A recent study
showed correspondence between rare focal subinsular vascular
lesions, WMLs and lacunes (Tomimoto et al., 2007).
NUMBER OF CEREBROVASCULAR LESIONS
Although a basic concept of VaD suggests that multiple small
infarcts, irrespective of their volume, can lead to intellectual
decline, only few studies have addressed this problem. The mean
number of infarcts in VaD was 5.8–6.7 compared to 3.2 in
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FIGURE 5 | Schematic interplay of pathogenic factors causing vascular cognitive impairment/dementia.
non-demented subjects (del Ser et al., 1990), but additional fac-
tors, such as age, degree of aging changes, extent of WMLs,
medial temporal lobe atrophy, etc, are involved in determining
intellectual decline (Pohjasvaara et al., 2000).
IMPORTANCE OF SMALL CEREBROVASCULAR LESIONS
The impact of small CVLs has been examined in several autopsy
series showing that lacunes, deep and periventricular WMLs may
contribute to cognitive dysfunction. Previous studies demon-
strated correlations between dementia and microvascular brain
damage throughout the brain, while macroscopic infarcts were
more frequent in the non-demented group (Esiri et al., 1999).
However, many brains showed more than one type of vascular
lesion (Vinters et al., 2000). Most were associated with severe
atherosclerosis, while CAAwas rare. These data were confirmed in
a clinico-pathologic study of 130 elderly subjects with and with-
out dementia. Among 91 demented patients, 27% had large old
infarcts, 52% multiple subcortical lacunes, 8% cortical and sub-
cortical microinfarcts, and 4% HS. Mild cognitive impairment
(MCI) subjects showed large cystic infarcts in 31%, multiple sub-
cortical lacunes in 52, the others had multiple infarcts of various
volumes, while of 20 cognitively unimpaired controls, two-thirds
had cystic solitary hemispheral infarcts, and 30% multiple sub-
cortical lacunes with preserved thalamus (Jellinger, 2008b).
The impact of small CVLs in autopsy series with vascu-
lar pathology confined to microinfarcts (Kövari et al., 2004)
and lacunes (Gold et al., 2005) showed a strong association
between the extent of cerebral microinfarcts and cognitive find-
ings. Lacunes, deep white matter and periventricular demyelina-
tion contributed equally to cognitive dysfunction and, contrary
to earlier neuroimaging studies, the relationship between CDR
scores and deep and periventricular WMLs was no longer signifi-
cant after controlling for lacunes in a multivariant model (Gold
et al., 2005). In both models, thalamic and basal ganglia, but
not deep white matter lacunes, significantly predicted cognitive
impairment (Giannakopoulos et al., 2007). Recent studies scor-
ing the severity of SVD showed a significant correlation between
SVD pathology severity and cognitive impairment (Launer et al.,
2011; Smallwood et al., 2012).
A preponderance of cortical and subcortical microinfarcts was
observed in a cohort of longitudinally followed autopsy cases of
AD, 36 with concomitant small cerebral infarcts with volumes
less than 10ml, which had no impact on cognitive decline (Lee
et al., 2000). These data, which were at variance to others sug-
gesting a contribution to cognitive decline of CBLs with volumes
of even less than 1ml (Corbett et al., 1994), were confirmed in a
larger sample showing that in AD with minor CVLs, the majority
of lesions were lacunes in basal ganglia and/or white matter, and
multiple microinfarcts (Jellinger, 2005).
Evaluation of the type and topographic pattern of CVLs in a
large autopsy series of demented subjects, in cases with “pure”
VaD, i.e., without essential concomitant Alzheimer type or other
pathologies, showed a significantly higher frequency of small sub-
cortical lesions (volume < 10ml) representing 70% than of large
infarcts (volume =10ml) involving one or both hemispheres
(32.5%) (Table 9). This pattern differed considerably from that
in cases with mixed dementia (AD + vascular encephalopathy),
where 56.6% revealed large, often lobar infarcts or multiple cor-
tical and subcortical lesions larger than 5–10mm in diameter
involving one or both hemispheres, whereas lacunes and small
subcortical microinfarcts were seen in only 36% (Table 10). These
data suggest different pathogenic mechanisms between both types
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Table 9 | Types and location of cerebrovascular lesions in vascular
dementia (total 188, personal series).
1) MULTIPLE INFARCTS (61 = 32.5%)
ACM bilateral 4
ACM left/right 9
ACM bilat. + ACPS/ACPD 2/1
ACM bilat. + ACP bilat. 2
ACMS + ACPS 4
ACMD + ACPD 4
ACP bilateral 3
ACP left/right 5/7
ACAS + ACMS 2
ACAD 1
multiple cortico-subcortical bilateral 12
multiple cortico-subcortical left hem. 2
2) SAE (SUBCORTICAL) (108 = 57.4%)
Basal ganglia 21
Basal ganglia + white matter 31
Basal ganglia + thalamus (+ white matter) 33
Basal ganglia brainstem (+ thalamus) 23
3) SID/STRATEGIC INFARCTS (19 = 10.1%)
Thalamus bilateral 9
Thalamus left 2
Thalamus + hippocampus 8
ACA, anterior cerebral artery; ACM, middle cerebral artery; ACP, posterior cere-
bral artery; D, S, right, left; SAE, subcortical arteriosclerotic encephalopathy; SID,
strategic infarct dementia.
of disorders (Jellinger, 2007b; Jellinger and Attems, 2010a,b).
According to the Religious Order Study, cerebral macroinfarcts
independently contribute to the likelihood of dementia, but do
not interact with AD pathology to increase the likelihood of
dementia beyond their additive effect (Schneider et al., 2004).
In conclusion, subcortical lacunes and multiple disseminated
microinfarcts appear to represent the most common morpho-
logic features of VaD, while large cystic infarcts are less common
(Kalaria et al., 2004; Ince, 2005; Jellinger, 2007a). This has been
confirmed in animal models of VaD due to chronic hypertension
(Kemper et al., 2001; Drobyshevsky et al., 2007). Brain atro-
phy accelerates cognitive decline in cerebral SVD (Jokinen et al.,
2012).
CEREBROVASCULAR LESIONS AND ALZHEIMER DISEASE
Recent emphasis on co-morbidity of AD and CVD, detected in
30–60% of AD brains and showing a large variety of lesions
(Jellinger and Attems, 2005; Schneider et al., 2007a,b), the link
between AD and atherosclerosis (Kalback et al., 2004; Ahtiluoto
et al., 2010), cognitive impairment associated with CAA, present
in up to 100% in AD brains (Greenberg et al., 2004; Attems et al.,
2005), significant cerebral microangiopathy (Bailey et al., 2004),
deficient clearance of amyloid across the BBB in AD (Zlokovic
et al., 2005) and many other data indicate an association between
CVD and AD. Vascular disorders are important features in
chronic neurodegeneration in AD. Therefore, neurovascular dys-
function could have a major role in the pathogenesis of AD
Table 10 | Types and location of cerebrovascular lesions in mixed
dementia (n = 83; personal series).
1) AD + MULTIPLE INFARCTS (47 = 56.6%)
ACM bilateral 7
ACM left 6
ACM right (+ lacunes basal ganglia) 3/1
ACM + ACA bilat 1
ACM + ACP left 2
ACM + ACP right 1
ACM + ACP left/right 3/3
ACM bilat. + ACPD 1
ACP bilateral 2
Multiple cortical and subcortical bilateral 13
Multiple left hemisphere 4
2) AD + SAE (SUBCORTICAL) (33 = 39.8%)
Lacunes basal ganglia 15
Lacunes basal ganglia + white matter 8
Lacunes basal ganglia + thalamus 10
3) AD + SID/STRATEGIC INFARCTS (3 = 3.6%)
Thalamus bilateral 2
Thalamus + hippocampus 1
ACM, middle cerebral artery; ACP, posterior cerebral artery; SAE, subcortical
arteriosclerotic encephalopathy; SID, strategic infarct dementia.
(Zlokovic et al., 2005; Stanimirovic and Friedman, 2012) that,
even by some authors, has been considered a primary vascu-
lar disorder (de la Torre, 2002). The association between circle
of Willis atherosclerosis and AD-type pathology provides fur-
ther evidence that vascular disease and AD are interrelated and
suggests that common etiologic or reciprocally synergetic patho-
physiological mechanisms promote both pathologies (Yarchoan
et al., 2012). Small vascular and AD-related pathologic deter-
minants of dementia have been demonstrated in the oldest-old
(Sinka et al., 2010). In elderly patients with subclinical or mild
AD and little functional brain reserve (with frequent entorhinal
tangles and moderate cortical plaques), either critically located
CVLs or cortical watershed microinfarcts may worsen cognitive
impairment due to a synergistic interaction of both pathologies
(Esiri et al., 1999; Miklossy, 2003). In advanced or full-blown
stages of AD, concomitant small vascular lesions do not signif-
icantly influence the overall state and progression of cognitive
decline that is mainly related to the severity and extent of AD
pathology overwhelming the effects of CVD (Lee et al., 2000;
Jellinger, 2001; Jellinger and Attems, 2005; Chui et al., 2006;
Jellinger, 2007a). However, other studies of AD cases with and
without CVLs showed no significant differences in MMSE scores
between groups, and no influence of the extent of vascular pathol-
ogy, severity of AD pathology, or the prevalence of hypertension
andmyocardial infarcts was observed (Crystal andDickson, 2002;
Jellinger, 2007b). Microinfarcts are an important correlate of
age-related VCI, but are not associated with an increased bur-
den of AD pathology (Richardson et al., 2012). Increased WMLs
are associated with decreased glucose metabolism and decline
in executive function, but do not affect AD-specific pathology
progression, suggesting that vascular contribution to dementia
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is probably additive although not necessarily independent of the
amyloid pathway (Lo and Jagust, 2012). The severity of β-amyloid
load in the brain is not significantly influenced by CVD except for
a shift from Aβ-40 to Aβ-42 in the thalamus of elderly subjects,
the reason of which is unknown (Aho et al., 2006). Other authors
found accumulation of brain Aβ increasing with age in VaD sub-
jects more than in elderly individuals without CVD (Lewis et al.,
2006). SVD without abnormal amyloid imaging is more common
than expected, and there is considerable clinical and MRI over-
lap in patients with SVD with and without abnormal Aβ imaging
(Lee et al., 2011). In general, patients with CVD show significantly
lower densities of plaques and tau pathology than “pure” AD for
every given level of cognitive deficit (Zekry et al., 2002). However,
others observed no major differences in neurodegenerative lesion
load between AD and AD+CVLs, except when these are located
in the temporal lobe and hippocampus, suggesting that this loca-
tion may be important in the pathophysiology of both VaD and
mixed dementia (del Ser et al., 2005; Sachdev et al., 2007). The
thresholds for vascular and degenerative lesions for distinguishing
“pure” VaD or AD frommixed cases have been critically discussed
(Gold et al., 2007).
PATHOPHYSIOLOGY OF VaD
VaD/VCD is a heterogeneous disorder, caused by vascular and/or
ischemic lesions involving various, often functionally important
brain areas and neuronal networks with deafferentation of frontal
and limbic cortical structures and interruption of basal ganglia-
cortical, cortico-cortical as well as ascending pathways by lesions
in basal ganglia, thalamus, white matter, and subfrontal areas.
The pattern of cognitive impairment is consistent with models
of disturbed cortical and subcortical circuits in producing cog-
nitive decline (Kramer et al., 2002), with interactions between
subcortical lesions and changes in cortex and hippocampus (Fein
et al., 2000) or correlations to frontal atrophy (Burton et al.,
2003). WMLs impair frontal functions regardless of their loca-
tion (Tullberg et al., 2004). They are associated with neocortical
more than entorhinal and hippocampal atrophy (Du et al., 2002),
that are more severe in AD than in VaD (Zarow et al., 2005),
and increase the risk of dementia, particularly in patients with
lacunar infarcts (Wen et al., 2004; Regan et al., 2006) and SVaD
(van de Pol et al., 2011). Myelin loss in frontal lobe white matter
was reduced in VaD compared to AD and DLB, which exhib-
ited lower myelin density compared to aged controls (Ihara et al.,
2010). Strategically situated small lesions that may be caused by
a mixture of large and SVD, destruct thalamocortical, striatocor-
tical and prefrontal-basal ganglia pathways, involving cognition,
memory, and behavior (Loeb, 2001; Szirmai et al., 2002; Zekry
et al., 2003b; Román, 2004). The association between cognitive
impairment with lacunes in basal gray and white matter resulting
from disruption of subcortico-frontal circuits (Reed et al., 2001;
D’Abreu and Ott, 2005) has been confirmed by recent studies on
the impact of subcortical lacunes/microinfarcts on cognitive dys-
function (Kövari et al., 2004; Gold et al., 2005; Giannakopoulos
et al., 2007) and by experimental models of ischemia (Naritomi,
1991; Sarti et al., 2002).
Neurochemical studies in VaD showed abnormalities in key
neurotransmitter systems, in particular in the basal forebrain
cholinergic system related to diffuse WMLs and other vascular
lesions involving the central axonal radiation fields for this pro-
jection pathway (Swartz et al., 2003), causing widespread discon-
nection of cholinergic projections. Since cholinergic mechanisms
play a role in the regulation of CBF (Hamel, 2004; Sato et al.,
2004), dysfunction of the cholinergic system may cause decreased
CBF and hyopoperfusion as critical factors in the pathogenesis of
VaD (Román et al., 2004; Tomimoto et al., 2005). While one study
showed loss of cholinergic functions only in VaD with concomi-
tant AD (Sharp et al., 2009), others confirmed the association
of cholinergic pathways with dementia severity in subcortical
VCI (Kim et al., 2012). Preservation of neurons in the choliner-
gic nucleus basalis in subcortical ischemic vascular disease was
reported (Jung et al., 2012). Cholinergic deficits in VaD have
been observed (Martin-Ruiz et al., 2000), and evidence of cholin-
ergic changes was seen in animal models of VaD (Román and
Kalaria, 2006). AD and mixed dementia (AD+VaD) usually have
greater deficits of ChAT activity in the temporal cortex than age-
matched controls and patients with VaD (Perry et al., 2005), and
severe cholinergic deficits in frontal and temporal cortices have
been reported in CADASIL (Keverne et al., 2006). Earlier studies
have shown a significant reduction of synaptophysin immunore-
activity as a measure of synapse protein density in the cortex of
Binswanger’s disease brains (Zhan et al., 1994). There is paucity
of data related to other neurotransmitter deficits in VaD, except
for reduction in vasopressin and histamine due to lesions in the
supraoptic and tuberomamillary nuclei (Ishunina et al., 2004).
CONCLUSIONS AND FUTURE PERSPECTIVES
VCI/VaD is a heterogenic group of disorders that provides many
challenges to the clinician, neuroradiologist and neuropatholo-
gist, in particular because evidence-based studies that seek to
provide definite answers often lack clear definitions and validated
consensus criteria of the disease (Murray et al., 2007).
Neuropathology has to describe the nature and severity of vas-
cular pathology using harmonized morphologic procedures and
criteria (Alafuzoff et al., 2012), addressing the question, whether
the CVLs present in a particular brain are of sufficient magnitude
and location to likely contribute or are even the sole substrate of
the profile which was demonstrated clinically. Pathologic exami-
nation is necessary to: (1) confirm or detect vascular brain injury,
especially for lesions that fall under the threshold of detection
by neuroimaging; (2) confirm or identify the type of under-
lying CVLs, e.g., arteriolosclerosis, (fibro) hyalinosis, CAA; (3)
ascertain the presence, type and extent of coincidental pathology.
On the other hand, many elderly patients exhibit morphologic
changes commonly seen in AD and VaD, but do not meet the
clinical criteria of dementia (see Jellinger and Attems, 2012;
Jellinger, 2013). A proposal for the assessment of key variables
to define the pathology of VaD by the Newcastle group intro-
duced a categorization of CVLs associated with cognitive impair-
ment according to six subtypes (Kalaria et al., 2004) (Table 11).
However, the existing concepts present difficulties in generalizing
clinico-pathologic correlations from patient to patient (Ince and
Fernando, 2003). The appreciation of the presence and extent of
morphologically verified vascular lesions in cognitively impaired
patients may be influenced by the heterogeneity of criteria for
Frontiers in Aging Neuroscience www.frontiersin.org April 2013 | Volume 5 | Article 17 | 12
Jellinger Pathology vascular cognitive impairment—update
Table 11 | Newcastle categorization of the major cerebrovascular
lesions associated with cognitive impairment (modified from Kalaria
et al., 2004).
VaD subtypes related to Newcastle
subtype
Large infarct or several infarcts
(>50ml loss of tissue); multi-infarct dementia
I
Multiple small or microinfarcts
(>3 with minimum diameter 5mm); small vessel
disease* (involving greater than three coronal levels;
hyalinization, CAA, lacunar infarcts, perivascular
changes, microhemorrhages)
White matter lesions/leukoaraiosis/Binswanger disease
II
Strategic infarcts (e.g., thalamus, hippocampus, basal
forebrain)
III
Cerebral hypoperfusion (hippocampal sclerosis,
ischemic–anoxic damage, cortical laminar necrosis,
borderzone infarcts involving three different coronal levels)
IV
Cerebral hemorrhages (lobar, intracerebral,
subarachnoidal)
V
Cerebrovascular changes with Alzheimer pathology
(above Braak stage III); mixed dementia (according to the
author’s experience stage IV would be appropriate)
Combined cerebrovascular lesions
VI
The age of the vascular lesion(s) should correspond with the time when disease
began. Post-stroke cases are usually included in subtypes I–III.
*Subtype I may result from large vessel occlusion (atherothromboembolism),
artery-to-artery embolism or cardioembolism. Subtype II usually involves
descriptions of arteriosclerosis, lipohyalinosis, hypertensive, arteriosclerotic,
amyloid or collagen angiopathy. Subtypes I, II, and V may result from aneurysms,
arterial dissections, arteriovenous malformations and various forms of vasculitis.
brain lesions, their quantification and interpretation applied in
different centers, as recently demonstrated (Pantoni et al., 2006).
The challenge of synthesizing a global “vascular pathology score”
depends on uniform and standardized study inclusion criteria
(Selnes and Vinters, 2006), and neuropathologic confirmation of
a clinical diagnosis of VaD/VCD remains largely subjective in view
of the fact of multiple pathologies involving the aged brain.
Despite various proposals for a categorization of major CVLs
(Román et al., 1993; Chui et al., 2000; Kalaria et al., 2004; Jellinger,
2007a), a harmonization of the criteria and techniques for the
assessment of cerebral lesions of presumable/possible vascular
origin in cognitively impaired is necessary (Pantoni et al., 2006;
Alafuzoff et al., 2012). Due to the high variability of morpholog-
ical findings and multifactorial pathogenesis of VCI, no generally
accepted morphologic scheme for quantitating vascular brain
injury and no validated neuropathological criteria for VaD have
been established to date [see (Jellinger, 2007a,b; Román, 2008)].
The revised NIA-AA guidelines recommend reporting all macro-
scopic vascular brain injuries andmicrovascular lesions (microin-
farcts/hemorrhages) in standard screening sections, multiple such
lesions being associated with increased likelihood of cognitive
Table 12 | Staging of the cerebrovascular lesions (Deramecourt et al.,
2012).
Score Staging
FRONTAL AND TEMPORAL LOBES
0 Normal appearance of brain, vessels, white matter,
and cortex
I Mild modification of vessel walls, perivascular spaces,
or white matter
II Moderate to severe but isolated modification of the
vessel walls (arteriolosclerosis or amyloid angiopathy),
usually associated with hemosiderin deposits in the
perivascular spaces
III Moderate to severe perivascular space dilatations
either in the deep or the juxtacortical white matter
IV Moderate to severe myelin loss
V Presence of cortical microinfarcts
VI Presence of large infarcts
HIPPOCAMPUS
0 Normal appearance
I Mild modification of vessel walls or perivascular
spaces
II Moderate to severe perivascular space dilatations
III Presence of microinfarcts (usually in Ammon horn or
the subiculum)
IV Presence of large infarcts
BASAL GANGLIA
0 Normal appearance
I Mild modification of vessel walls or perivascular
spaces
II Moderate to severe perivascular space dilatations
III Presence of microinfarcts
IV Presence of large infarcts
TOTAL VASCULAR SCORE
Frontal lobe +
Temporal lobe +
Hippocampus +
Basal ganglia
(/20)
impairment (Hyman et al., 2012; Montine et al., 2012). Another
recent staging strategy proposing semiquantitative assessment of
CVLs in 4 brain areas with a score ranging from I to IV/VI
(Table 12) (Deramecourt et al., 2012) awaits further validation.
Mixed type dementia, being frequent in elderly demented per-
sons, is diagnosed when a combination of several pathologies,
e.g., AD with cerebrovascular and/or Lewy pathology, is present
(Jellinger, 2007a; Ferrer, 2010). Vascular brain injury is com-
monly encountered in seniors with and without AD pathology
(Ferrer, 2010; Grinberg and Thal, 2010; Jellinger, 2007a,b); but
uniform and reproducible criteria are currently not available.
Further development of homogeneous and harmonized neu-
ropathologic definitions and procedures in classifying vascu-
lar lesions and/or methods to more accurately characterize the
independent severity of vascular and other brain lesions remain
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an important priority for the future. Development of common
standards represents a first step in a process of use, valida-
tion and refinement. Universal and interinstitutional use of the
same standards will help to identify individuals with cognitive
impairment, will make future clinico-pathologic studies com-
parable, and, by integrating knowledge, will accelerate the pace
of progress. An integrative, rather than a strictly taxonomic,
approach to the study and elucidation of how vascular disease
mechanisms contribute to the development of dementias has
been proposed (Kling et al., 2013). Accurate diagnosis of both
VaD/CVD and mixed dementia and further exploration of the
structural correlates of cognitive impairment in order to get
better insights into the impact of CVLs and their interrelation-
ship with Alzheimer-type and other pathologies on cognitive
function are among the most important challenges of modern
neurosciences.
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